Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer

Published:2014-05-13 Issue:3 Volume:145 Page:615-623
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Lee Hee Jin,Park In Ah,Park So Yeon,Seo An Na,Lim Bora,Chai Yun,Song In Hye,Kim Na Eun,Kim Joo Young,Yu Jong Han,Ahn Jin-Hee,Gong Gyungyub

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-014-2983-x.pdf

Reference30 articles.

1. Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752

2. Cancer Genome Atlas N (2012) Comprehensive molecular portraits of human breast tumours. Nature 490:61–70

3. Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474–1481

4. Morrow M (2013) Personalizing extent of breast cancer surgery according to molecular subtypes. Breast 22(Suppl 2):S106–S109

5. Park YH, Lee S, Cho EY et al (2010) Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status. Cancer Chemother Pharmacol 66:507–516

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic mechanisms of resistance to tyrosine kinase inhibitors in HER2 amplified breast cancer;2024-04-22

2. Effects of hormone receptor status on patient clinic and survival in HER2 positive breast cancer;Japanese Journal of Clinical Oncology;2024-02-09

3. Clinicopathological characteristics, treatment patterns and out-comes in patients with HER2-positive breast cancer based on hormone receptor status: a retrospective study;2024-01-08

4. Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer;Clinical Radiology;2024-01

5. Genomic Alterations Correlated to Trastuzumab Resistance and Clinical Outcomes in HER2+/HR- Breast Cancers of Patients Living in Northwestern China;Journal of Cancer;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3